Index -
P/E 58.64
EPS (ttm) 2.17
Insider Own 6.36%
Shs Outstand 29.47M
Perf Week -6.93%
Market Cap 3.75B
Forward P/E 39.33
EPS next Y 3.24
Insider Trans -1.81%
Shs Float 27.62M
Perf Month -16.65%
Income 66.51M
PEG 1.65
EPS next Q 0.20
Inst Own 111.39%
Short Float 11.60%
Perf Quarter -21.62%
Sales 840.11M
P/S 4.47
EPS this Y 29.54%
Inst Trans 1.76%
Short Ratio 6.35
Perf Half Y -33.03%
Book/sh 21.57
P/B 5.90
EPS next Y 42.73%
ROA 9.39%
Short Interest 3.20M
Perf Year -23.93%
Cash/sh 12.52
P/C 10.17
EPS next 5Y 35.59%
ROE 10.86%
52W Range 123.00 - 225.00
Perf YTD -31.36%
Dividend Est. -
P/FCF 47.60
EPS past 5Y -
ROIC 9.97%
52W High -43.44%
Beta 1.29
Dividend TTM -
Quick Ratio 7.44
Sales past 5Y 57.80%
Gross Margin 84.65%
52W Low 3.46%
ATR (14) 5.61
Dividend Ex-Date -
Current Ratio 9.01
EPS Y/Y TTM 514.98%
Oper. Margin 5.93%
RSI (14) 30.28
Volatility 2.18% 1.72%
Employees 1246
Debt/Eq 0.05
Sales Y/Y TTM 27.11%
Profit Margin 7.92%
Recom 1.65
Target Price 218.12
Option/Short Yes / Yes
LT Debt/Eq 0.05
EPS Q/Q 129.22%
Payout 0.00%
Rel Volume 1.44
Prev Close 129.71
Sales Surprise 3.14%
EPS Surprise 140.32%
Sales Q/Q 22.75%
Earnings May 05 AMC
Avg Volume 504.59K
Price 127.25
SMA20 -7.32%
SMA50 -13.25%
SMA200 -28.70%
Trades
Volume 718,091
Change -1.90%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-20-24 Upgrade
BofA Securities
Neutral → Buy
$220 → $255
May-08-24 Downgrade
BofA Securities
Buy → Neutral
$265 → $225
Apr-19-24 Initiated
RBC Capital Mkts
Outperform
$285
Mar-19-24 Initiated
Morgan Stanley
Overweight
$250
Feb-06-24 Resumed
KeyBanc Capital Markets
Overweight
$278
Jan-19-24 Initiated
Jefferies
Buy
$245
Jan-02-24 Downgrade
Stifel
Buy → Hold
$210
Dec-13-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$245 → $187
Jul-19-23 Initiated
Robert W. Baird
Outperform
$371
Apr-14-23 Initiated
Mizuho
Buy
$300
Mar-29-23 Initiated
UBS
Buy
$300
Dec-13-22 Upgrade
Goldman
Neutral → Buy
$245 → $308
Dec-13-22 Initiated
KeyBanc Capital Markets
Overweight
$287
Apr-13-22 Initiated
Truist
Buy
$315
Apr-06-22 Initiated
Wolfe Research
Peer Perform
$270
Mar-02-22 Resumed
BofA Securities
Buy
$270
Jan-04-21 Downgrade
BofA Securities
Buy → Neutral
Dec-15-20 Downgrade
Goldman
Buy → Neutral
$162 → $209
Nov-03-20 Upgrade
Oppenheimer
Underperform → Perform
Nov-03-20 Upgrade
BofA Securities
Neutral → Buy
$125 → $155
Show Previous Ratings
Jun-13-25 11:21AM
08:27AM
Jun-12-25 12:59PM
Jun-11-25 09:51AM
Jun-06-25 09:02AM
11:30AM
Loading…
Jun-04-25 11:30AM
Jun-03-25 08:00AM
Jun-02-25 10:23AM
May-30-25 08:00AM
May-29-25 08:47AM
May-27-25 08:15AM
May-26-25 08:30AM
08:30AM
May-22-25 06:46AM
06:38AM
07:49AM
Loading…
May-21-25 07:49AM
May-20-25 08:53AM
May-15-25 08:55AM
May-08-25 09:50AM
May-07-25 12:00PM
09:55AM
May-06-25 12:29PM
08:36AM
(Thomson Reuters StreetEvents)
03:08AM
May-05-25 06:54PM
05:10PM
04:02PM
May-02-25 10:56AM
09:20AM
Apr-29-25 08:00AM
08:00AM
Loading…
Apr-21-25 08:00AM
Apr-01-25 08:00AM
Mar-12-25 11:30AM
Mar-11-25 05:04AM
Mar-06-25 08:00AM
Mar-04-25 11:53PM
08:06AM
Feb-28-25 04:03AM
Feb-25-25 02:53PM
09:50AM
Feb-12-25 09:45AM
Feb-11-25 08:40AM
(Thomson Reuters StreetEvents)
07:01AM
02:08AM
Feb-10-25 05:30PM
05:10PM
04:19PM
04:02PM
Feb-09-25 08:02AM
Feb-07-25 07:07AM
Feb-05-25 09:15AM
Feb-03-25 10:00AM
Jan-13-25 06:45AM
Jan-09-25 07:30AM
(Investor's Business Daily)
Jan-07-25 09:50AM
08:00AM
Jan-06-25 08:15AM
Dec-30-24 08:00AM
Dec-23-24 02:25PM
Dec-05-24 12:12PM
Dec-04-24 11:30AM
Nov-20-24 02:08PM
Nov-19-24 08:00AM
Nov-18-24 10:00AM
Nov-15-24 08:00AM
Nov-11-24 06:45AM
Nov-06-24 08:00AM
06:31AM
Nov-05-24 02:09AM
Nov-04-24 06:30PM
05:20PM
04:02PM
Oct-30-24 09:15AM
08:00AM
Oct-18-24 12:00PM
Oct-11-24 12:15PM
Oct-07-24 08:00AM
Oct-04-24 05:04PM
Sep-18-24 09:50AM
Sep-06-24 06:43PM
Sep-02-24 09:50AM
Aug-23-24 07:35AM
Aug-21-24 04:02PM
Aug-09-24 12:20PM
Aug-07-24 10:48AM
Aug-06-24 06:30PM
05:35PM
04:02PM
04:02PM
Aug-05-24 10:10AM
09:16AM
Aug-02-24 08:00AM
Jul-29-24 10:59AM
09:21AM
06:45AM
Jul-23-24 08:00AM
Jul-22-24 11:35AM
08:39AM
08:00AM
04:52AM
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
mcCormick Shawn Director Jun 04 '25 Option Exercise 16.00 4,000 64,000 28,046 Jun 06 06:06 PM Rondoni John See Remarks May 19 '25 Sale 149.38 1,734 259,025 13,766 May 21 04:05 PM JOHN RONDONI Officer May 19 '25 Proposed Sale 149.38 1,734 259,025 May 19 04:01 PM mcCormick Shawn Director May 02 '25 Sale 160.00 360 57,600 24,046 May 05 07:31 PM SHAWN T MCCORMICK Director May 02 '25 Proposed Sale 157.90 360 56,844 May 02 04:23 PM Ban Randy See Remarks Mar 03 '25 Sale 185.84 3,947 733,496 7,259 Mar 05 04:47 PM Rondoni John Chief Technology Officer Mar 03 '25 Sale 185.60 2,287 424,467 15,500 Mar 05 04:46 PM JOHN RONDONI Officer Mar 03 '25 Proposed Sale 185.60 2,287 424,467 Mar 03 04:27 PM RANDALL BAN Officer Feb 28 '25 Proposed Sale 184.02 3,947 726,327 Feb 28 04:18 PM Ban Randy See Remarks Feb 13 '25 Option Exercise 67.63 25,000 1,690,750 32,843 Feb 18 06:44 PM Ban Randy See Remarks Feb 13 '25 Sale 183.50 25,584 4,694,766 7,259 Feb 18 06:44 PM Rondoni John Chief Technology Officer Feb 11 '25 Sale 170.49 583 99,396 10,424 Feb 13 08:14 PM RANDALL BAN Officer Feb 13 '25 Proposed Sale 187.01 25,584 4,784,464 Feb 13 04:30 PM JOHN RONDONI Officer Feb 11 '25 Proposed Sale 170.49 583 99,396 Feb 11 04:01 PM Rondoni John Chief Technology Officer Jan 07 '25 Sale 215.00 58 12,470 11,322 Jan 10 04:05 PM JOHN RONDONI Officer Jan 07 '25 Proposed Sale 215.00 58 12,470 Jan 07 04:02 PM Rondoni John Chief Technology Officer Nov 01 '24 Option Exercise 61.38 8,703 534,219 20,051 Nov 05 04:01 PM Rondoni John Chief Technology Officer Nov 01 '24 Sale 193.47 8,703 1,683,731 11,348 Nov 05 04:01 PM JOHN RONDONI Officer Nov 01 '24 Proposed Sale 193.46 8,703 1,683,723 Nov 01 04:47 PM Ebeling Philip Officer Sep 11 '24 Proposed Sale 247.28 5,453 1,348,445 Sep 11 06:01 PM McCormick Shawn Director Sep 09 '24 Sale 220.00 800 176,000 23,140 Sep 11 05:02 PM Rondoni John Chief Technology Officer Sep 09 '24 Sale 215.00 31 6,665 11,348 Sep 11 05:01 PM SHAWN T MCCORMICK Director Sep 09 '24 Proposed Sale 220.00 800 176,000 Sep 09 04:09 PM JOHN RONDONI Officer Sep 09 '24 Proposed Sale 215.00 31 6,665 Sep 09 04:08 PM Rondoni John Chief Technology Officer Aug 22 '24 Option Exercise 71.00 5,000 355,000 16,379 Aug 23 04:09 PM Rondoni John Chief Technology Officer Aug 22 '24 Sale 189.83 5,000 949,143 11,379 Aug 23 04:09 PM JOHN RONDONI Officer Aug 22 '24 Proposed Sale 189.82 5,000 949,100 Aug 22 04:22 PM Ban Randy Chief Commercial Officer Aug 15 '24 Option Exercise 42.15 16,139 680,259 19,195 Aug 19 08:14 PM Ban Randy Chief Commercial Officer Aug 16 '24 Option Exercise 42.15 4,861 204,891 7,917 Aug 19 08:14 PM Ban Randy Chief Commercial Officer Aug 15 '24 Sale 193.10 16,139 3,116,397 3,056 Aug 19 08:14 PM Ban Randy Chief Commercial Officer Aug 16 '24 Sale 188.55 4,861 916,549 3,056 Aug 19 08:14 PM RANDALL A BAN Officer Aug 16 '24 Proposed Sale 188.55 4,861 916,560 Aug 16 04:34 PM Ebeling Philip Officer Aug 15 '24 Proposed Sale 194.84 43,901 8,553,615 Aug 15 05:36 PM McCormick Shawn Director Aug 14 '24 Option Exercise 0.94 8,537 8,025 23,940 Aug 15 04:19 PM RANDALL A BAN Officer Aug 15 '24 Proposed Sale 193.10 16,139 3,116,380 Aug 15 04:13 PM Ebeling Philip Officer Aug 14 '24 Proposed Sale 190.03 4,596 873,393 Aug 14 04:50 PM Griffin Jerry C Director Jul 26 '24 Proposed Sale 126.53 5,952 753,086 Jul 26 05:02 PM